101 related articles for article (PubMed ID: 21637915)
41. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
42. Expression and activation of proteases in co-cultures.
Paduch R; Kandefer-Szerszeń M
Exp Toxicol Pathol; 2011 Jan; 63(1-2):79-87. PubMed ID: 19836935
[TBL] [Abstract][Full Text] [Related]
43. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
44. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
[TBL] [Abstract][Full Text] [Related]
45. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.
Dang D; Atakilit A; Ramos DM
Anticancer Res; 2008; 28(4B):2049-54. PubMed ID: 18751374
[TBL] [Abstract][Full Text] [Related]
46. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
[TBL] [Abstract][Full Text] [Related]
47. The glycosylated IgII extracellular domain of EMMPRIN is implicated in the induction of MMP-2.
Papadimitropoulou A; Mamalaki A
Mol Cell Biochem; 2013 Jul; 379(1-2):107-13. PubMed ID: 23716178
[TBL] [Abstract][Full Text] [Related]
48. CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts.
Aoki M; Koga K; Miyazaki M; Hamasaki M; Koshikawa N; Oyama M; Kozuka-Hata H; Seiki M; Toole BP; Nabeshima K
BMC Cancer; 2019 Sep; 19(1):912. PubMed ID: 31510956
[TBL] [Abstract][Full Text] [Related]
49. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
50. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
[TBL] [Abstract][Full Text] [Related]
51. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
van den Oord JJ; Paemen L; Opdenakker G; de Wolf-Peeters C
Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
[TBL] [Abstract][Full Text] [Related]
52. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
Siwik DA; Kuster GM; Brahmbhatt JV; Zaidi Z; Malik J; Ooi H; Ghorayeb G
J Mol Cell Cardiol; 2008 Jan; 44(1):210-7. PubMed ID: 17869266
[TBL] [Abstract][Full Text] [Related]
53. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
54. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts.
Saad S; Gottlieb DJ; Bradstock KF; Overall CM; Bendall LJ
Cancer Res; 2002 Jan; 62(1):283-9. PubMed ID: 11782389
[TBL] [Abstract][Full Text] [Related]
55. Direct contact with bone marrow stromal cells promotes the invasions of SHI-1 leukemia cells.
Li ZJ; Chen ZX; Cen JN; He J; Qiu QC
Chin Med J (Engl); 2013 Jul; 126(14):2731-5. PubMed ID: 23876905
[TBL] [Abstract][Full Text] [Related]
56. Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147.
Knutti N; Kuepper M; Friedrich K
FEBS J; 2015 Nov; 282(21):4187-200. PubMed ID: 26277583
[TBL] [Abstract][Full Text] [Related]
57. Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts.
Hanata K; Yamaguchi N; Yoshikawa K; Mezaki Y; Miura M; Suzuki S; Senoo H; Ishikawa K
Arch Histol Cytol; 2007 Dec; 70(5):267-77. PubMed ID: 18431027
[TBL] [Abstract][Full Text] [Related]
58. Expression of EMMPRIN modulates mediators of tumor invasion in oral squamous cell carcinoma.
Siu A; Chang J; Lee C; Lee S; Lee C; Ramos DM
J Calif Dent Assoc; 2013 Nov; 41(11):831-8. PubMed ID: 24341135
[TBL] [Abstract][Full Text] [Related]
59. Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts.
Hatanaka M; Higashi Y; Fukushige T; Baba N; Kawai K; Hashiguchi T; Su J; Zeng W; Chen X; Kanekura T
Anticancer Res; 2014 Dec; 34(12):7091-6. PubMed ID: 25503136
[TBL] [Abstract][Full Text] [Related]
60. Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinases (MMPs) as regulators of tumor-host interaction in a spontaneous metastasis model in rats.
Donadio AC; Remedi MM; Susperreguy S; Frede S; Gilardoni MB; Tang Y; Pellizas CG; Yan L
Histochem Cell Biol; 2008 Dec; 130(6):1155-64. PubMed ID: 18769934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]